Estimating progression rates for human papillomavirus infection from epidemiological data.
about
Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasiaType-specific prevalence of high-risk human papillomavirus by cervical cytology and age: Data from the health check-ups of 7,014 Korean women.Natural history of anal dysplasia in an HIV-infected clinical care cohort: estimates using multi-state Markov modeling.Inference of type-specific HPV transmissibility, progression and clearance rates: a mathematical modelling approachNatural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.The Swedish translation and cross-cultural adaptation of the Functional Assessment of Chronic Illness Therapy - Cervical Dysplasia (FACIT-CD): linguistic validity and reliability of the Swedish version.Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.Calibration of complex models through Bayesian evidence synthesis: a demonstration and tutorial.Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United KingdomMechanistic mathematical models: An underused platform for HPV research.Cervical cancer screening among HIV-infected women: an economic evaluation in a middle-income country.Projected impact of Cervarix® vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom.Women with abnormal Pap smear result: a qualitative study of Swedish healthcare professionals' experiences.Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis
P2860
Q27010447-3E616B81-7EE7-4763-8908-BCF9BA96B45CQ30712681-3E63107A-FD72-4C46-99A6-B22E904DBB1BQ34015521-311A7DEE-3288-4214-9E05-197EDE1A81DFQ34490267-E4ED95AD-1553-4B91-B762-BD46E51A721AQ35048280-023761A7-B93B-4C1C-BBD0-198DF886E3A3Q36333120-A8363E89-2F7A-4744-AD74-06272137416DQ36675963-3B3DBABB-8F16-49F5-9725-1D3980CA0FDDQ36843345-C4D87A28-709E-4C46-8029-207431262D81Q37502417-6912209D-0221-4135-A134-2558554809D3Q38673360-31469EC0-2925-4B4A-996F-9579F246ECC5Q39553755-7743AE04-25B0-43A4-8CE7-4A3967FE77F1Q41648405-BD00E513-B556-4BC7-ADCD-627538C92590Q47380012-193D1D28-B99B-44B0-8A61-EEE1D722789CQ57089346-6096C004-B3FA-4FCF-88FF-68CF28FA82F7
P2860
Estimating progression rates for human papillomavirus infection from epidemiological data.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Estimating progression rates f ...... ion from epidemiological data.
@ast
Estimating progression rates f ...... ion from epidemiological data.
@en
type
label
Estimating progression rates f ...... ion from epidemiological data.
@ast
Estimating progression rates f ...... ion from epidemiological data.
@en
prefLabel
Estimating progression rates f ...... ion from epidemiological data.
@ast
Estimating progression rates f ...... ion from epidemiological data.
@en
P2093
P2860
P356
P1476
Estimating progression rates f ...... ion from epidemiological data.
@en
P2093
Kate Soldan
William John Edmunds
Yoon Hong Choi
P2860
P356
10.1177/0272989X09336140
P50
P577
2009-06-12T00:00:00Z